Literature DB >> 6647500

Opiate regulation of maternal behavior in the rat.

C T Grimm, R S Bridges.   

Abstract

The effects of the opiate agonist morphine, the opiate antagonist naloxone and the weak opiate nonanalgesic dextrorphan on the expression of maternal behavior were investigated in a series of three experiments. In the first experiment treatment of rats with morphine (5 mg/kg, subcutaneously) after ovariectomy and hysterectomy on day 17 of gestation resulted in a disruption in the onset and quality of maternal responsiveness in the homecage and in a T-maze test. The duration of morphine's acute disruptive action was 2-4 hours. In the second experiment concurrent treatment of morphine-injected rats with naloxone prevented the disruptive effects of morphine in both the homecage and T-maze tests. The effects of morphine did not appear to result from a severe alteration in activity levels as measured in an open-field test, although morphine did increase activity slightly by the fifth day of treatment. In the third experiment treatment of rats after ovariectomy plus hysterectomy on day 17 of gestation with dextrorphan failed to disrupt maternal behavior. These results indicate that morphine disrupts maternal behavior through an opiate receptor mechanism, and suggests to us that endogenous opiates may mediate the expression of maternal behavior under certain physiological conditions.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6647500     DOI: 10.1016/0091-3057(83)90336-2

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  9 in total

1.  A role for the periaqueductal gray in switching adaptive behavioral responses.

Authors:  M H Sukikara; S R Mota-Ortiz; M V Baldo; L F Felício; N S Canteras
Journal:  J Neurosci       Date:  2006-03-01       Impact factor: 6.167

2.  Leucine-enkephalin-like immunoreactive fibers in the medial preoptic area of the rat: their distribution and origin.

Authors:  M Yamano; M Tohyama; S Shiosaka; Y Shiotani; S Inagaki; S Kito
Journal:  Exp Brain Res       Date:  1985       Impact factor: 1.972

Review 3.  Effects of opioids on the parental brain in health and disease.

Authors:  James E Swain; S Shaun Ho; Helen Fox; David Garry; Susanne Brummelte
Journal:  Front Neuroendocrinol       Date:  2019-05-22       Impact factor: 8.606

4.  Early postpartum resting-state functional connectivity for mothers receiving buprenorphine treatment for opioid use disorder: A pilot study.

Authors:  James E Swain; S Shaun Ho
Journal:  J Neuroendocrinol       Date:  2019-07-29       Impact factor: 3.627

Review 5.  The role of mesocorticolimbic dopamine in regulating interactions between drugs of abuse and social behavior.

Authors:  Kimberly A Young; Kyle L Gobrogge; Zuoxin Wang
Journal:  Neurosci Biobehav Rev       Date:  2010-06-23       Impact factor: 8.989

6.  Puerperal blockade of cholecystokinin (CCK1) receptors disrupts maternal behavior in lactating rats.

Authors:  Cláudia M Miranda-Paiva; Antonia G Nasello; Alberto J Yim; Luciano F Felicio
Journal:  J Mol Neurosci       Date:  2002 Feb-Apr       Impact factor: 3.444

7.  Morphine effects on maternal aggression, pup care and analgesia in mice.

Authors:  M Haney; K A Miczek
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

Review 8.  Neural circuits underlying crying and cry responding in mammals.

Authors:  John D Newman
Journal:  Behav Brain Res       Date:  2007-02-16       Impact factor: 3.332

9.  Reduced Child-Oriented Face Mirroring Brain Responses in Mothers With Opioid Use Disorder: An Exploratory Study.

Authors:  James E Swain; S Shaun Ho
Journal:  Front Psychol       Date:  2022-02-04
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.